ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers.
Handattu SP, Garber DW, Horn DC, Hughes DW, Berno B, Bain AD, Mishra VK, Palgunachari MN, Datta G, Anantharamaiah GM, Epand RM.
Handattu SP, et al.
J Biol Chem. 2007 Jan 19;282(3):1980-8. doi: 10.1074/jbc.M606231200. Epub 2006 Nov 16.
J Biol Chem. 2007.
PMID: 17114186
Free article.
Two homologous apoA-I mimetic peptides, 3F-2 and 3F(14), differ in their in vitro antiatherogenic properties (Epand, R. M., Epand, R. F., Sayer, B. G., Datta, G., Chaddha, M., and Anantharamaiah, G. M. (2004) J. Biol. Chem. 279, 51 …
Two homologous apoA-I mimetic peptides, 3F-2 and 3F(14), differ in their in vitro antiatherogenic properties (Epand, R. M., Epand, R. …